Chris Grimes-Crompton

Chris Grimes-Crompton joined Steba biotech in April 2020 as Chief Commercial Officer with responsibilities for Commercial Strategy, Operations, Business Development and Investor relations.

Before joining Steba, Chris served as Head of the Liver Disease Franchise at Gilead Sciences EMEA with responsibilities for Commercialization of the Hepatitis Franchise and Development compounds in NASH.

After completing a BSc. in Medicinal Chemistry, Chris joined the UK pharmaceutical industry, covering a number of roles in sales, marketing and market access with Merck and AstraZeneca before progressing into international roles where he has held leadership positions with AstraZeneca, Amgen and BMS. Chris has more than 20 year experience in developing, launching and commercializing brands across multiple therapy areas and geographies.